The Wnt pathway, cell-cycle activation and β-amyloid: novel therapeutic strategies in Alzheimer's disease?
- 1 May 2003
- journal article
- review article
- Published by Elsevier in Trends in Pharmacological Sciences
- Vol. 24 (5), 233-238
- https://doi.org/10.1016/s0165-6147(03)00100-7
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- Wnt signaling involvement in β-amyloid-dependent neurodegenerationNeurochemistry International, 2002
- Erratic expression of DNA polymerases by β‐amyloid causes neuronal deathThe FASEB Journal, 2002
- Protein kinase C inhibits amyloid β‐peptide neurotoxicity by acting on members of the Wnt pathwayThe FASEB Journal, 2002
- Genetic variability in the insulin signalling pathway may contribute to the risk of late onset Alzheimer's diseaseJournal of Neurology, Neurosurgery & Psychiatry, 2002
- Involvement of DNA polymerase β in DNA replication and mutagenic consequencesJournal of Molecular Biology, 2002
- The multifaceted roles of glycogen synthase kinase 3β in cellular signalingProgress in Neurobiology, 2001
- Wnt signaling function in Alzheimer’s diseaseBrain Research Reviews, 2000
- Dickkopf-1, an inhibitor of the Wnt signaling pathway, is induced by p53Oncogene, 2000
- Memantine restores long term potentiation impaired by tonic N-methyl-d-aspartate (NMDA) receptor activation following reduction of Mg2+ In hippocampal slicesNeuropharmacology, 1999
- Re-entry into the cell cycle: a mechanism for neurodegeneration in Alzheimer diseaseMedical Hypotheses, 1999